急性冠脉综合征后多种生物标志物与全因及病因特异性死亡风险的关联:PLATO生物标志物研究二次分析
该研究基于PLATO试验生物标志物亚组17 095例急性冠脉综合征患者,分析基线胱抑素C、GDF-15、高敏C反应蛋白、高敏肌钙蛋白I/T和NT-proBNP与全因及病因特异性死亡的关系。中位随访期间782例(4.6%)死亡,NT-proBNP和GDF-15与全因死亡关联最强,调整后HR分别为2.96和2.65。NT-proBNP与心力衰竭死亡关联最强(约8倍风险),GDF-15与其他血管及非血管死亡关联最强。
要点
- NT-proBNP和GDF-15是与ACS后全因死亡关联最强的生物标志物。
- NT-proBNP与心力衰竭死亡风险约8倍升高相关,与心律失常/心源性猝死风险约4倍升高相关。
- GDF-15与其他血管性和非血管性死亡关联最强,可能与主要出血死亡相关。
核心结论
- 在急性冠脉综合征患者中,基线NT-proBNP和GDF-15水平是与全因死亡关联最强的标志物,其关联源于与心力衰竭死亡以及心律失常和心源性猝死死亡的关联。
- GDF-15与其他血管性或非血管性原因死亡关联最强,并可能与主要出血死亡相关。
研究设计与样本
- 本分析为生物标志物亚组二次分析,共纳入17 095例患者,基线测定胱抑素C、GDF-15、高敏C反应蛋白、高敏肌钙蛋白I和T以及NT-proBNP水平。
- 主要结局包括心肌梗死死亡、心力衰竭死亡、心源性猝死/心律失常死亡、出血死亡、操作相关死亡、其他血管性死亡、非血管性死亡以及全因死亡。
主要发现
- 患者中位年龄62.0岁(四分位距54.0-71.0),17 095例中782例(4.6%)在随访期间死亡。
- 对于全因死亡,NT-proBNP和GDF-15是最强标志物,比较上四分位与下四分位的调整后HR分别为2.96(95%CI 2.33-3.76)和2.65(95%CI 2.17-3.24)。
- 关于心力衰竭死亡,NT-proBNP与约8倍风险升高相关,C反应蛋白、GDF-15和胱抑素C与约3倍风险升高相关。
- 关于心源性猝死/心律失常死亡,NT-proBNP与约4倍风险升高相关,GDF-15与风险翻倍相关。
- GDF-15与其他血管性和非血管性死亡关联最强,并可能与主要出血死亡相关(HR 4.91,95%CI 1.39-17.43)。
临床怎么用
- 在ACS患者中检测基线NT-proBNP和GDF-15有助于识别全因死亡及病因特异性死亡高风险人群。
- NT-proBNP升高提示心力衰竭死亡和心律失常/心源性猝死风险增加,GDF-15升高提示其他血管性、非血管性及可能的出血死亡风险增加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Mortality remains at about 5% within a year after an acute coronary syndrome event. Prior studies have assessed biomarkers in relation to all-cause or cardiovascular deaths but not across multiple causes. OBJECTIVE: To assess if different biomarkers provide information about the risk for all-cause and cause-specific mortality. DESIGN, SETTING, AND PARTICIPANTS: The Platelet Inhibition and Patient Outcomes (PLATO) trial randomized 18 624 patients with acute coronary syndrome to ticagrelor or clopidogrel from October 2006 through July 2008. In this secondary analysis biomarker substudy, 17 095 patients participated. MAIN OUTCOMES AND MEASURES: Death due to myocardial infarction, heart failure, sudden cardiac death/arrhythmia, bleeding, procedures, other vascular causes, and nonvascular causes, as well as all-cause death. EXPOSURES: At baseline, levels of cystatin-C, growth differentiation factor-15 (GDF-15), high-sensitivity C-reactive protein, high-sensitivity troponin I and T, and N-terminal pro-B-type natriuretic peptide (NT-proBNP) were determined. RESULTS: The median (interquartile range) age of patients was 62.0 (54.0-71.0) years. Of 17 095 patients, 782 (4.6%) died during follow-up. The continuous associations between biomarkers and all-cause and cause-specific mortality were modeled using Cox models and presented as hazard ratio (HR) comparing the upper vs lower quartile. For all-cause mortality, NT-proBNP and GDF-15 were the strongest markers with adjusted HRs of 2.96 (95% CI, 2.33-3.76) and 2.65 (95% CI, 2.17-3.24), respectively. Concerning death due to heart failure, NT-proBNP was associated with an 8-fold and C-reactive protein, GDF-15, and cystatin-C, with a 3-fold increase in risk. Regarding sudden cardiac death/arrhythmia, NT-proBNP was associated with a 4-fold increased risk and GDF-15 with a doubling in risk. Growth differentiation factor-15 had the strongest associations with other vascular and nonvascular deaths and was possibly associated with death due to major bleeding (HR, 4.91; 95% CI, 1.39-17.43). CONCLUSIONS AND RELEVANCE: In patients with acute coronary syndrome, baseline levels of NT-proBNP and GDF-15 were strong markers associated with all-cause death based on their associations with death due to heart failure as well as due to arrhythmia and sudden cardiac death. Growth differentiation factor-15 had the strongest associations with death due to other vascular or nonvascular causes and possibly with death due to bleeding. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT00391872.
引用
- Lindholm D, James SK, Gabrysch K, et al. Association of Multiple Biomarkers With Risk of All-Cause and Cause-Specific Mortality After Acute Coronary Syndromes: A Secondary Analysis of the PLATO Biomarker Study. JAMA Cardiol. 2018. PMID: 30427997. doi:10.1001/jamacardio.2018.3811
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。